April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
50 mg/mL, 10 mL vial, package of 10 (NDC 00409-2053-10)<br />
Ketalar injection, JHP<br />
10 mg/mL, 20 mL vials (NDC 42023-0113-10)<br />
Reason for the Shortage<br />
• JHP has Ketalar on shortage due to increased demand.<br />
• Mylan Institutional states the reason for the shortage is increased demand.<br />
• Hospira has ketamine on shortage due to manufacturing delays.<br />
• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011.<br />
Product will become available in stages as production resumes.<br />
• Bedford Laboratories has multiple products affected by this suspension of manufacturing.<br />
Availability of all products, including those not manufactured at Ben Venue, is updated as<br />
information changes on the Bedford Laboratories website.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=592<br />
Source: www.ashp.org<br />
Amphetamine Mixed Salts, Immediate-Release Tablets<br />
March 23, <strong>2012</strong><br />
Products Affected - Description<br />
Amphetamine mixed salts immediate-release tablets, Teva<br />
5 mg tablets, 100 count (NDC 00555-0971-02)<br />
7.5 mg tablets, 100 count (NDC 00555-0775-02)<br />
10 mg tablets, 100 count (NDC 00555-0972-02)<br />
12.5 mg tablets, 100 count (NDC 00555-0776-02)<br />
15 mg tablets, 100 count (NDC 00555-0777-02)<br />
20 mg tablets, 100 count (NDC 00555-0973-02)<br />
30 mg tablets, 100 count (NDC 00555-0974-02)<br />
Adderall, Teva<br />
5 mg tablets, 100 count (NDC 00555-0762-02)<br />
7.5 mg tablets, 100 count (NDC 00555-0763-02)<br />
10 mg tablets, 100 count (NDC 00555-0764-02)<br />
12.5 mg tablets, 100 count (NDC 00555-0765-02)<br />
15 mg tablets, 100 count (NDC 00555-0766-02)<br />
20 mg tablets, 100 count (NDC 00555-0767-02)<br />
30 mg tablets, 100 count (NDC 00555-0764-02)<br />
Amphetamine mixed salts immediate-release tablets, Sandoz<br />
5 mg tablets, 100 count (NDC 00185-0084-01)<br />
10 mg tablets, 100 count (NDC 00185-0111-01)<br />
20 mg tablets, 100 count (NDC 00185-0401-01)<br />
30 mg tablets, 100 count (NDC 00185-0404-01)<br />
Amphetamine mixed salts immediate-release tablets, CorePharma<br />
5 mg tablets, 100 count (NDC 64720-0130-10)<br />
10 mg tablets, 100 count (NDC 64720-0132-10)<br />
20 mg tablets, 100 count (NDC 64720-0135-10)<br />
30 mg tablets, 100 count (NDC 64720-0136-10)<br />
Reason for the Shortage<br />
• Teva states the shortage is due to DEA quota restrictions.<br />
• CorePharma cannot provide a reason for the shortage.<br />
• Sandoz states the shortage is due to increased demand.<br />
59